Revenue

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Biopharmaceutical Medicines Revenue	6.66T	6.07T	Log In	Log In	Log In	Upgrade
Chemical Medicines Revenue	517.00B	531.39B	Log In	Log In	Log In	Upgrade
Other Segments Revenue	7.24B	5.82B	Log In	Log In	Log In	Upgrade
Adjustments to Revenue	-3,438.85B	-3,050.04B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Domestic Revenue	1.48T	1.55T	Log In	Log In	Log In	Upgrade
Americas Revenue	-	-	Log In	Log In	Log In	Upgrade
Asia Revenue	211.23B	192.46B	Log In	Log In	Log In	Upgrade
Europe Revenue	1.65T	1.50T	Log In	Log In	Log In	Upgrade
North America Revenue	279.01B	168.09B	Log In	Log In	Log In	Upgrade
Central and South America Revenue	123.60B	140.96B	Log In	Log In	Log In	Upgrade

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Biopharmaceutical Medicines Operating Income	1.47T	1.20T	Log In	Log In	Log In	Upgrade
Chemical Medicines Operating Income	14.11B	9.18B	Log In	Log In	Log In	Upgrade
Other Segments Operating Income	1.37B	505.60M	Log In	Log In	Log In	Upgrade
Adjustments to Operating Income	-693.18B	-716.79B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.